Protein G-MMAF is a Protein-drug conjugate (PDC) of Protein G with MMAF (Monomethylauristatin F) through a linker. >95% protein G were conjugated with MMAF, the DPR (drug protein ratio) n = 1-3 drugs per protein. Protein G is expressed in group C and G streptococcal bacteria. It is a ~60-kDa cell surface protein. It binds to most mammalian immunoglobulins primarily through their Fc regions. MMAF is a synthetic antineoplastic agent and a potent inhibitor of tubulin polymerization which applied as a cytotoxic component of the anti-cancer antibody-drug conjugates such as vorsetuzumab mafodotin and SGN-CD19A. This product is for research use only.
Product Details |
Species Reactivity | Bind to most mammalian immunoglobulins primarily through their Fc regions. |
---|
Source | E. coli |
---|
Type | Recombinant Protein |
---|
Measurement | A280 of 0.1% solution: 1.0 |
---|
Isoelectric point (pI) | 4.5 |
---|
DAR (Drug to Antibody Ratio) | >95% protein conjugated, 1-3 drugs per protein |
---|
Conjugate | protein G conjugated with -MMAF |
---|
Purity | >95% |
---|
Molecular Weight | ~21,600 (Apparent MW by SDS-PAGE: 32,000) |
---|
Protein Concentration | 1 mg/ml |
---|
Formulation | Liquid |
---|
Storage Condition | 4°C for short time, -20°C or -80°C for long time. |
---|
Storage Buffer | 20 mM Sodium Borate, 6% Trehalose, pH8.0 |